These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1669 related articles for article (PubMed ID: 19346330)

  • 1. Bile acids: regulation of synthesis.
    Chiang JY
    J Lipid Res; 2009 Oct; 50(10):1955-66. PubMed ID: 19346330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
    Song KH; Li T; Owsley E; Strom S; Chiang JY
    Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR an emerging therapeutic target for the treatment of atherosclerosis.
    Mencarelli A; Fiorucci S
    J Cell Mol Med; 2010 Jan; 14(1-2):79-92. PubMed ID: 20041971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis.
    Katafuchi T; Makishima M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.
    Di Ciaula A; Bonfrate L; Baj J; Khalil M; Garruti G; Stellaard F; Wang HH; Wang DQ; Portincasa P
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
    Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
    Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acids are nutrient signaling hormones.
    Zhou H; Hylemon PB
    Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific mechanisms of bile acid homeostasis and activation of FXR-FGF19 signaling in preterm and term neonatal pigs.
    Vonderohe C; Guthrie G; Stoll B; Chacko S; Dawson H; Burrin DG
    Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G117-G133. PubMed ID: 34851728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP.
    Davis RA; Miyake JH; Hui TY; Spann NJ
    J Lipid Res; 2002 Apr; 43(4):533-43. PubMed ID: 11907135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.
    Shin DJ; Osborne TF
    J Biol Chem; 2009 Apr; 284(17):11110-20. PubMed ID: 19237543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
    Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids as metabolic regulators.
    Li T; Chiang JY
    Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis.
    Zhou X; Cao L; Jiang C; Xie Y; Cheng X; Krausz KW; Qi Y; Sun L; Shah YM; Gonzalez FJ; Wang G; Hao H
    Nat Commun; 2014 Sep; 5():4573. PubMed ID: 25183423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
    Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
    J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
    Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid nuclear receptor FXR and digestive system diseases.
    Ding L; Yang L; Wang Z; Huang W
    Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.